Firefly Neuroscience, INC Form 4 insider transactions

Firefly Neuroscience's President and COO, David DeCaprio, vested 44,872 shares of common stock after performance conditions were met for previously granted restricted stock units.

Gregory Lipschitz, CEO and Director of FIREFLY NEUROSCIENCE, INC., increased his beneficial ownership by 65,988 shares through RSU vesting.

Firefly Neuroscience director Arun Menawat received a grant of 73,892 deferred stock units, vesting quarterly over 12 months.

Firefly Neuroscience, Inc. Director Brian M. Posner was granted 49,262 deferred stock units under the company's 2024 Long-Term Incentive Plan.

Stella Vnook, a Director at Firefly Neuroscience, Inc., was granted 49,262 deferred stock units under the company's 2024 Long-Term Incentive Plan.

Windsor Private Capital LP and its affiliated entities have sold a significant portion of their common stock in Firefly Neuroscience, Inc., ceasing to be a 10% beneficial owner.

Windsor Private Capital LP and affiliated entities, including directors, reported the sale of 102,675 shares of Firefly Neuroscience, Inc. common stock in mid-October 2025.

Windsor Private Capital LP and its affiliates, a 10% owner and director group, sold 166,572 shares of Firefly Neuroscience, Inc. common stock in October 2025.

Arun Menawat, a director at Firefly Neuroscience, was granted 125,000 restricted stock units (RSUs) on May 19, 2025, under the company's 2024 Long-Term Incentive Plan.

Gregory Lipschitz, CEO of Firefly Neuroscience, was granted 197,963 restricted stock units as part of the company's 2024 Long-Term Incentive Plan.

David DeCaprio, President and COO of Firefly Neuroscience, was granted 131,976 restricted stock units (RSUs) as part of the company's 2024 Long-Term Incentive Plan.

Arun Swarup Menawat, Chairman of Firefly Neuroscience, received 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

Brian Posner, a director at Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

David DeCaprio, a director at Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

Paul Krzywicki, CFO of Firefly Neuroscience, received 10,000 restricted stock units and an option to purchase 15,000 shares on March 10, 2025.

Stella Vnook, a director at Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

David Ian Johnson, Executive Chairman of Firefly Neuroscience, acquired 557,885 shares of restricted common stock on October 22, 2024, as per his employment agreement.

Firefly Neuroscience's white paper reveals the BNA platform's positive impact on disease management in 2,253 U.S. patients, enhancing treatment compliance and improving patient outcomes.